Suppr超能文献

通过视频会议在线开展的年轻男性伴侣关系教育与艾滋病毒预防:2GETHER全国随机对照试验方案

Relationship Education and HIV Prevention for Young Male Couples Administered Online via Videoconference: Protocol for a National Randomized Controlled Trial of 2GETHER.

作者信息

Newcomb Michael E, Sarno Elissa L, Bettin Emily, Carey James, Ciolino Jody D, Hill Ricky, Garcia Christopher P, Macapagal Kathryn, Mustanski Brian, Swann Gregory, Whitton Sarah W

机构信息

Department of Medical Social Sciences, Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, IL, United States.

Department of Preventive Medicine, Northwestern University, Chicago, IL, United States.

出版信息

JMIR Res Protoc. 2020 Jan 27;9(1):e15883. doi: 10.2196/15883.

Abstract

BACKGROUND

Young men who have sex with men have a high HIV incidence, and a substantial proportion of incident infections occur in the context of main partnerships. However, romantic relationships also provide numerous benefits to individual health and wellbeing. 2GETHER is a relationship education and HIV prevention program for young male couples, and the 2GETHER USA randomized controlled trial (RCT) was launched to establish the efficacy of an online version of 2GETHER.

OBJECTIVE

The objective of 2GETHER is to optimize relationship functioning in young male couples as a method to improve communication about sexual risk behaviors and reduce HIV transmission. In the 2GETHER USA study, 2GETHER was adapted for online administration to couples across the United States via videoconferencing. The intervention in question aims to address the unique needs of couples from varied racial/ethnic backgrounds and geographic regions.

METHODS

This is a comparative effectiveness RCT of 2GETHER USA relative to existing public health practice (control). 2GETHER USA is a hybrid group- and individual-level intervention that delivers three weekly online group discussion sessions for skills delivery, followed by two individualized couple sessions that focus on skills implementation in each couple. The control condition differs by participant HIV status: (1) the Testing Together protocol for concordant HIV-negative couples; (2) medication adherence and risk reduction counseling for concordant HIV-positive couples; or (3) both protocols for serodiscordant couples. Follow-up assessments are delivered at 3-, 6-, 9-, and 12-months post-intervention in both conditions. Testing for rectal and urethral Chlamydia and Gonorrhea occurs at baseline and 12-month follow-up. The primary behavioral outcome is condomless anal sex with serodiscordant serious partners or any casual partners. The primary biomedical outcome is sexually transmitted infection incidence at a 12-month follow-up.

RESULTS

As of October 11, 2019, the trial has enrolled and randomized 140 dyads (Individual N=280). Enrollment will continue until we randomize 200 dyads (N=400). Assessment of intervention outcomes at 3-, 6-, 9-, and 12-months is ongoing.

CONCLUSIONS

2GETHER is innovative in that it integrates relationship education and HIV prevention for optimizing the health and wellbeing of young male couples. The 2GETHER USA online adaptation has the potential to reach couples across the United States and reduce barriers to accessing health care services that are affirming of sexual minority identities for those who live in rural or under-resourced areas.

TRIAL REGISTRATION

ClinicalTrials.gov NCT03284541; https://clinicaltrials.gov/ct2/show/NCT03284541.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/15883.

摘要

背景

与男性发生性行为的年轻男性感染艾滋病毒的几率很高,而且相当一部分新发感染发生在主要伴侣关系中。然而,浪漫关系也给个人健康和幸福带来诸多益处。“携手同行”是一项针对年轻男性伴侣的关系教育和艾滋病毒预防项目,“携手同行美国”随机对照试验(RCT)旨在确定该项目在线版本的效果。

目的

“携手同行”项目的目标是优化年轻男性伴侣间的关系,以此作为改善性风险行为沟通和减少艾滋病毒传播的一种方法。在“携手同行美国”研究中,“携手同行”项目经改编后通过视频会议面向美国各地的伴侣进行在线管理。该干预措施旨在满足来自不同种族/族裔背景和地理区域的伴侣的独特需求。

方法

这是一项“携手同行美国”相对于现有公共卫生实践(对照)的比较效果随机对照试验。“携手同行美国”是一种混合式团体和个体层面的干预措施,每周进行三次在线团体讨论课程以传授技能,随后进行两次针对每对伴侣的个性化课程,重点是在每对伴侣中实施技能。对照条件因参与者的艾滋病毒感染状况而异:(1)针对艾滋病毒检测结果均为阴性的伴侣的“共同检测”方案;(2)针对艾滋病毒检测结果均为阳性的伴侣的药物依从性和风险降低咨询;或(3)针对血清学不一致伴侣的两种方案。在两种情况下,干预后3个月、6个月、9个月和12个月进行随访评估。在基线和12个月随访时检测直肠和尿道衣原体及淋病。主要行为结果是与血清学不一致的固定伴侣或任何临时性伴侣发生无保护肛交。主要生物医学结果是12个月随访时的性传播感染发病率。

结果

截至2019年10月11日,该试验已招募并随机分配了140对伴侣(个体N = 280)。招募工作将持续进行,直到随机分配200对伴侣(N = 400)。对干预后3个月、6个月、9个月和12个月的干预结果评估正在进行中。

结论

“携手同行”项目的创新之处在于将关系教育和艾滋病毒预防相结合,以优化年轻男性伴侣的健康和幸福。“携手同行美国”的在线改编版本有潜力覆盖美国各地的伴侣,并减少那些生活在农村或资源匮乏地区、对性少数群体身份持肯定态度的人在获得医疗服务方面的障碍。

试验注册

ClinicalTrials.gov NCT03284541;https://clinicaltrials.gov/ct2/show/NCT03284541。

国际注册报告识别码(IRRID):DERR1-10.2196/15883。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d69/7011124/5ebff3763ef1/resprot_v9i1e15883_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验